116 related articles for article (PubMed ID: 22593082)
1. Progesterone promotes focal adhesion formation and migration in breast cancer cells through induction of protease-activated receptor-1.
Diaz J; Aranda E; Henriquez S; Quezada M; Espinoza E; Bravo ML; Oliva B; Lange S; Villalon M; Jones M; Brosens JJ; Kato S; Cuello MA; Knutson TP; Lange CA; Leyton L; Owen GI
J Endocrinol; 2012 Aug; 214(2):165-75. PubMed ID: 22593082
[TBL] [Abstract][Full Text] [Related]
2. Progesterone receptor enhances breast cancer cell motility and invasion via extranuclear activation of focal adhesion kinase.
Fu XD; Goglia L; Sanchez AM; Flamini M; Giretti MS; Tosi V; Genazzani AR; Simoncini T
Endocr Relat Cancer; 2010 Jun; 17(2):431-43. PubMed ID: 20233709
[TBL] [Abstract][Full Text] [Related]
3. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
[TBL] [Abstract][Full Text] [Related]
4. Progesterone pre-treatment potentiates EGF pathway signaling in the breast cancer cell line ZR-75.
Carvajal A; Espinoza N; Kato S; Pinto M; Sadarangani A; Monso C; Aranda E; Villalon M; Richer JK; Horwitz KB; Brosens JJ; Owen GI
Breast Cancer Res Treat; 2005 Nov; 94(2):171-83. PubMed ID: 16175315
[TBL] [Abstract][Full Text] [Related]
5. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.
Cui X; Lazard Z; Zhang P; Hopp TA; Lee AV
Oncogene; 2003 Oct; 22(44):6937-41. PubMed ID: 14534541
[TBL] [Abstract][Full Text] [Related]
6. Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells.
Lindberg K; Ström A; Lock JG; Gustafsson JA; Haldosén LA; Helguero LA
J Cell Physiol; 2010 Jan; 222(1):156-67. PubMed ID: 19780039
[TBL] [Abstract][Full Text] [Related]
7. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
8. Thrombin enhanced migration and MMPs expression of human chondrosarcoma cells involves PAR receptor signaling pathway.
Chen HT; Tsou HK; Tsai CH; Kuo CC; Chiang YK; Chang CH; Fong YC; Tang CH
J Cell Physiol; 2010 Jun; 223(3):737-45. PubMed ID: 20175118
[TBL] [Abstract][Full Text] [Related]
9. Csk homologous kinase associates with RAFTK/Pyk2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration.
McShan GD; Zagozdzon R; Park SY; Zrihan-Licht S; Fu Y; Avraham S; Avraham H
Int J Oncol; 2002 Jul; 21(1):197-205. PubMed ID: 12063569
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line.
Shi Z; Hodges VM; Dunlop EA; Percy MJ; Maxwell AP; El-Tanani M; Lappin TR
Mol Cancer Res; 2010 Apr; 8(4):615-26. PubMed ID: 20353997
[TBL] [Abstract][Full Text] [Related]
11. Signaling from protease-activated receptor-1 inhibits migration and invasion of breast cancer cells.
Kamath L; Meydani A; Foss F; Kuliopulos A
Cancer Res; 2001 Aug; 61(15):5933-40. PubMed ID: 11479236
[TBL] [Abstract][Full Text] [Related]
12. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells.
Boire A; Covic L; Agarwal A; Jacques S; Sherifi S; Kuliopulos A
Cell; 2005 Feb; 120(3):303-13. PubMed ID: 15707890
[TBL] [Abstract][Full Text] [Related]
13. Arachidonic acid induces an increase of β-1,4-galactosyltransferase I expression in MDA-MB-231 breast cancer cells.
Villegas-Comonfort S; Serna-Marquez N; Galindo-Hernandez O; Navarro-Tito N; Salazar EP
J Cell Biochem; 2012 Nov; 113(11):3330-41. PubMed ID: 22644815
[TBL] [Abstract][Full Text] [Related]
14. Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4.
Kaufmann R; Rahn S; Pollrich K; Hertel J; Dittmar Y; Hommann M; Henklein P; Biskup C; Westermann M; Hollenberg MD; Settmacher U
J Cell Physiol; 2007 Jun; 211(3):699-707. PubMed ID: 17323377
[TBL] [Abstract][Full Text] [Related]
15. RAFTK/Pyk2 tyrosine kinase mediates the association of p190 RhoGAP with RasGAP and is involved in breast cancer cell invasion.
Zrihan-Licht S; Fu Y; Settleman J; Schinkmann K; Shaw L; Keydar I; Avraham S; Avraham H
Oncogene; 2000 Mar; 19(10):1318-28. PubMed ID: 10713673
[TBL] [Abstract][Full Text] [Related]
16. Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism.
Payne SL; Fogelgren B; Hess AR; Seftor EA; Wiley EL; Fong SF; Csiszar K; Hendrix MJ; Kirschmann DA
Cancer Res; 2005 Dec; 65(24):11429-36. PubMed ID: 16357151
[TBL] [Abstract][Full Text] [Related]
17. Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators.
Faivre E; Skildum A; Pierson-Mullany L; Lange CA
Steroids; 2005; 70(5-7):418-26. PubMed ID: 15862825
[TBL] [Abstract][Full Text] [Related]
18. Effect of progesterone receptor a predominance on breast cancer cell migration into bone marrow fibroblasts.
McGowan EM; Saad S; Bendall LJ; Bradstock KF; Clarke CL
Breast Cancer Res Treat; 2004 Feb; 83(3):211-20. PubMed ID: 14758091
[TBL] [Abstract][Full Text] [Related]
19. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
20. TAE226-induced apoptosis in breast cancer cells with overexpressed Src or EGFR.
Golubovskaya VM; Virnig C; Cance WG
Mol Carcinog; 2008 Mar; 47(3):222-34. PubMed ID: 17849451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
